- Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg. + Teneligliptin Hydrobromide Hydrate IP eq.to Teneligliptin 10mg.
- Administration of dapagliflozin or teneligliptin decreased the serum concentration of ALT in NAFLD patients without type 2 diabetes mellitus. With dapagliflozin, body weight decreased, which was related to changes in total body water and body fat mass (UMIN000027304).
- As directed by the physician.`